Evidence map›Paper›PMID 40855131›Full record

ArticleNature structural & molecular biology2025

The mitotic STAG3-cohesin complex shapes male germline nucleome.

Masahiro Nagano, Bo Hu, Kosuke Ogata, Fumiya Umemura, Yukiko Ishikura, Shinnosuke Suzuki, Christos C Katsifis, Masanori Yoshinaga, Gabriele Litos, Kota Nagasaka and 21 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature structural & molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Masahiro Nagano *Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan. nagano@anat2.med.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0003-1228-4015
Bo Hu *Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Kosuke OgataDepartment of Molecular Systems BioAnalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-0634-3990
Fumiya UmemuraInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Yukiko IshikuraInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Shinnosuke SuzukiDivision of Germ Cell Biology, National Institute for Basic Biology, National Institutes of Natural Sciences, Myodaiji, Japan.
Christos C KatsifisDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-5289-8914
Masanori YoshinagaDepartment of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0001-5642-9752
Gabriele LitosResearch Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
Kota NagasakaResearch Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
Wen TangResearch Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.
Yoshiaki NosakaInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Hiromichi SasadaInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Hanbo WangInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Daichi KondoInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Yoshitaka KatouInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Ken MizutaInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-3922-1009
Yukihiro YabutaInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Hiroshi OhtaInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
Francisca Nathalia de Luna VitorinoDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0001-8543-2299
Hiroshi ArimaDepartment of Hematology, Kyoto University Hospital, Kyoto, Japan.
Takafumi IchikawaInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-0490-4176
Michele GabrieleDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-5393-9084
Jacek MajewskiDepartment of Human Genetics, McGill University, Montreal, Quebec, Canada.ORCID http://orcid.org/0000-0003-3572-9558
Benjamin A GarciaDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, USA.ORCID http://orcid.org/0000-0003-3596-4750
Osamu TakeuchiDepartment of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0002-1260-6232
Shosei YoshidaDivision of Germ Cell Biology, National Institute for Basic Biology, National Institutes of Natural Sciences, Myodaiji, Japan.ORCID http://orcid.org/0000-0001-8861-1866
Anders S HansenDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-7540-7858
Jan-Michael PetersResearch Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Vienna, Austria.ORCID http://orcid.org/0000-0003-2820-3195
Yasushi IshihamaDepartment of Molecular Systems BioAnalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0001-7714-203X
Mitinori SaitouInstitute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan. saitou@anat2.med.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0002-2895-6798

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Germ cells are unique in that they tailor chromatin toward generating totipotency. Accordingly, mammalian spermatogonia, including spermatogonial stem cells that constitute the source for male gametes, acquire distinctive chromatin organization with weak insulation, but the underlying mechanism remains unknown. Here we show that STAG3, so far known to exclusively form meiotic cohesins, generates a mitotic cohesin for male germline nucleome programming in mice. Owing to its shorter chromatin residence, STAG3-cohesin attenuates topologically associating domains, rewires enhancer-promoter and Polycomb-mediated repressive interactions, and facilitates finer and more strengthened compartments, establishing a distinctive spermatogonial nucleome. Moreover, in the absence of STAG3-cohesin, spermatogonial stem cells show an impaired differentiation priming for spermatogenesis. Mitotic STAG3-cohesin is also expressed in human B cells and their malignant variations, promoting their propagation. Our findings on mitotic STAG3-cohesin elucidate a principle of male germline nucleome programming, demonstrate an unexpected mitotic role for STAG3 and might potentially improve understanding of human malignancies.

Indexed as

Cell Cycle ProteinsChromosomal Proteins, Non-HistoneMitosisNuclear ProteinsSpermatogoniaAnimalsChromatinCohesinsHumansMaleMiceSpermatogenesisCell Cycle ProteinsChromatinChromosomal Proteins, Non-HistoneCohesinsNuclear Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.